Tuberculosis: Prognosis, Treatment, and the Critical Importance of Early Care

Tuberculosis (TB): Curable with Proper Treatment

TB is caused by Mycobacterium tuberculosis. It's treatable and preventable, but remains a top infectious killer globally due to delayed diagnosis, drug resistance, and healthcare access gaps.

Prognosis Without Treatment

• Miliary TB / TB meningitis: Rapid progression—death in weeks to months
• Pulmonary TB: Slower—50% die within 5 years; survivors may develop chronic fibrotic disease
• Overall untreated mortality: ~50-70% within 10 years

Standard Treatment (Drug-Sensitive TB)

• Intensive phase (2 months): Isoniazid + Rifampin + Pyrazinamide + Ethambutol
• Continuation phase (4 months): Isoniazid + Rifampin
• Total: 6 months (longer for meningeal/bone TB)
• Cure rates: >95% with adherence

Drug-Resistant TB (DR-TB)

• MDR-TB: Resistant to isoniazid + rifampin → 9-12 month regimens (bedaquiline, linezolid, etc.)
• XDR-TB: Additional resistance to fluoroquinolones + injectables → complex, individualized regimens
• Success rates: MDR-TB ~60%, XDR-TB ~30-40%

Critical Success Factors

• Early diagnosis: Molecular tests (GeneXpert) detect TB + rifampin resistance in 2 hours
• Directly Observed Therapy (DOT): Ensures adherence, prevents resistance
• Contact tracing: Identifies latent TB infection (LTBI) for preventive treatment
• Comorbidity management: HIV coinfection (ART essential), diabetes, malnutrition
• Social support: Nutrition, housing, stigma reduction, economic assistance

Latent TB Infection (LTBI)

• Asymptomatic, non-infectious, but 5-10% lifetime reactivation risk
• Treatment: 3-4 months (rifapentine/isoniazid weekly) or 6-9 months (isoniazid daily)
• Indicated for: HIV+, recent contacts, immunocompromised, healthcare workers

Global Targets (WHO End TB Strategy)

• 90% reduction in TB deaths by 2030 (vs. 2015)
• 80% reduction in incidence
• Zero catastrophic costs for TB-affected families

If you suspect TB (cough >2 weeks, fever, night sweats, weight loss), seek testing immediately. Early treatment saves lives and stops transmission.